Connect with us

Company News

PACS Group, Inc. announces pricing of its upsized IPO

PACS Group, Inc. announced the pricing of its upsized initial public offering of 21,428,572 shares of its common stock being sold by the Company at a public offering price of $21.00 per share, for total gross proceeds of approximately $450 million, before deducting underwriting discounts and commissions and offering expenses. In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3,214,284 shares of the Company’s common stock at the initial public offering price, less underwriting discounts and commissions. PACS will not receive any proceeds from any sale of shares by the selling stockholders. The shares are expected to begin trading on the New York Stock Exchange on April 11, 2024, under the ticker symbol “PACS.” The offering is expected to close on April 15, 2024, subject to customary closing conditions.

Citigroup, J.P. Morgan and Truist Securities are acting as lead book-running managers for the offering. RBC Capital Markets and Goldman Sachs & Co. LLC are acting as joint book-running managers. Stephens Inc., KeyBanc Capital Markets, Oppenheimer & Co. and Regions Securities LLC are acting as co-manager.

A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission.
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!